The Pandemic's Impact: Navigating the rise in autism spectrum disorder diagnoses
The COVID-19 pandemic's fifth year sees a rise in ASD diagnoses among children globally. Dr. Renuka Desai witnesses a surge in cases at her clinic, em
Stay updated with breaking news from Increased Stress. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The COVID-19 pandemic's fifth year sees a rise in ASD diagnoses among children globally. Dr. Renuka Desai witnesses a surge in cases at her clinic, em
Article - The Four-day Work Week: How Does It Work? - In a trial conducted between June and December of 2022, 61 companies across the UK took a leap into the world of the four-day workweek. The results were impressive, with 92% of employers choosing to stick with this new approach. This surge in popularity has sparked interest across various industries in the UK, prompting many to contemplate the switch.
Law Colleges have no autonomy to decide their curriculum. If they don't follow the curriculum dictated by the Bar Council, necessarily they will face some penal action and their course will not be recognised, Kerala HC Judge said, Education News, Times Now
New Delhi [India], September 19 (ANI/Mediawire): A new company, Good Nutrition Private Limited, is entering the nutraceutical space this month with a wide range of products. The first of these is Good Nutrition's Nutritional Smoothie Mix, available in both Whey protein and Soy protein. Whichever protein you select, you can be sure the Smoothie Mix will complete your daily nutrition needs. What's more, it is also an effective weight management and weight loss aid. Choose from two delicious flavours - Chocolate and Berry Punch. Either way, it's a tasty start to your health journey. I...
Adalimumab Market Size Estimated to Reach $4.3 Billion by 2025 Owing to an Unhealthy Lifestyle Adaptation, Increased Stress in Daily Life, Dysfunction in the Immune System Are Factors Which Are Estimated to Boost the Growth of the Adalimumab Market. BriefingWire.com, 3/17/2021 - Adalimumab Market size is estimated to reach $4.3 Billion by 2025 and is poised to grow at a CAGR of 4.98% during the forecast period 2020-2025. Adalimumab, with brand name of Humira and Exemptia, which is an anti-TNF medication used to treat rheumatoid arthritis, psoriatic arthritis, C...